October 17, 2017
Speaker: Jane F. Barlow
Real Endpoints LLC
Implications for bempedoic acid?
• Creating and delivering on payer expectations is key
• Payers will welcome an option that is lower cost than PCSK9 inhibitors
• There remains a sizeable number of patients that can’t get to goal with statins and ezetimibe
• Payers’ feedback on the profiles of the combination and bempedoic acid:
‒ On-going cardiovascular outcomes trials – potential limitation
‒ New mechanism of action – positive
‒ LDL-C lowering ability and safety profile – positive
‒ Oral route of administration; less complexity – positive
‒ Combination drug (bempedoic acid + ezetimibe) – positive
view event >November 17, 2023
Chicago, IL
Rob O'Brien, SVP Specialty
A day-long meeting in Chicago focused on healthcare and pharmaceutical marketplace trends, including a review of the specialty pipeline, implications of the IRA, and potential pharmaceutical disruptions. Rob O’Brien, SVP of Specialty, presenting.
October 19, 2023 - October 20, 2023
Las Vegas, NV
Jane Barlow, Chief Clinical Officer
A meeting of healthcare executives representing integrated delivery networks, managed care nurses, and medical directors.
October 18, 2023 - October 20, 2023
New York, NY
Susan Raiola, President
Stakeholders in the cancer care ecosystem meet to discuss issues linked to cost, quality, and access. RE President, Susan Raiola, will be speaking on patient support.
October 10, 2023 - October 12, 2023
Orlando, FL
Rob O'Brien, SVP Specialty
Pharma and payer execs gather to discuss the future of managed care pharmacy. Rob O’Brien provides a perspective on the self-insured employer market.
October 8, 2023 - October 10, 2023
Carlsbad, CA
Roger Longman, Co-Founder and Chairman
Top biotech CEOs gather from around the globe to discuss pressing industry issues. Roger Longman, Co-founder and Chairman, is participating.
September 24, 2023 - August 26, 2023
Zurich, Switzerland
Jeff Berkowitz, CEO
An annual summit hosted by HBM to exchange views about the latest developments in the biopharma industry. Jeff Berkowitz, CEO of Real Endpoints, will provide an overview of why market access matters now, more than ever.
Manager
Payer & Channel Insights, Marketing Analytics & Business Insights